kabutan

Fuji Pharma Co.,Ltd.(4554) Summary

4554
TSE Prime
Fuji Pharma Co.,Ltd.
1,876
JPY
-4
(-0.21%)
Jan 29, 3:30 pm JST
12.26
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
1,881.9
Jan 29, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
12.0
PBR
0.98
Yield
2.51%
Margin Trading Ratio
20.40
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,875 JPY 12.24 USD
Previous Close Jan 28
1,880 JPY 12.31 USD
High Jan 29, 12:32 pm
1,897 JPY 12.39 USD
Low Jan 29, 9:05 am
1,832 JPY 11.96 USD
Volume
66,000
Trading Value
0.12B JPY 0.81M USD
VWAP
1871.44 JPY 12.24 USD
Minimum Trading Value
187,600 JPY 1,226 USD
Market Cap
0.05T JPY 0.31B USD
Number of Trades
356
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
305
1-Year High Feb 7, 2025
1,184
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 35,100 169,600 4.83
Jan 16, 2026 31,700 167,700 5.29
Jan 9, 2026 31,300 181,500 5.80
Dec 26, 2025 24,600 195,600 7.95
Dec 19, 2025 10,800 193,600 17.93
Company Profile
Fuji Pharma Co., Ltd. is a leading generic pharmaceutical company, specializing in fertility treatments and contrast agents. The company is also expanding into new drugs and biosimilars.
Sector
Pharmaceuticals
Fuji Pharma Co., Ltd. is a major generic drug manufacturer, primarily focusing on injectable products such as hormone preparations for obstetrics and gynecology, and urinary tract and vascular contrast agents for radiology. The company operates through five branch offices nationwide, engaging in the development, manufacturing, and sales of pharmaceuticals. With one consolidated subsidiary, Fuji Pharma conducts product trading and financial lending with its Thai subsidiary. Operating under a single pharmaceutical business segment, the company offers a diverse product lineup to meet a wide range of medical needs. As a pharmaceutical manufacturer with particular strengths in obstetrics, gynecology, and radiology, Fuji Pharma Co., Ltd. conducts business both domestically and internationally.